SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is trending as investors weigh strong backlog growth and a newly announced multi-satellite communications contract against concerns over market volatility and sector-wide sentiment. Community discourse is highly polarized, with bulls highlighting the company's expanding project pipeline as a long-term catalyst, while bears argue that recent price action is a trap and point to upcoming mission risks and potential dilution.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is experiencing heightened volatility and intense community debate as shareholders react to aggressive share dilution and the company's potential exclusion from MSCI indexes. Investors remain deeply divided, with some betting on a long-term Bitcoin treasury play while others express frustration over the stock's divergence from Bitcoin's price action and continued reliance on capital raises.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is experiencing significant momentum and investor attention as it progresses toward its merger with Agility Robotics, a pure-play humanoid robotics firm backed by strategic heavyweights like NVIDIA, Amazon, and Foxconn. The stock is being buoyed by the broader robotics investment theme and notable institutional stake disclosures, leading community members to draw optimistic parallels to previous successful SPAC transitions in the infrastructure and automation sectors.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber shares are experiencing intense volatility following a proposed $250 million convertible senior note offering, which has sparked immediate investor concerns regarding potential shareholder dilution despite the company's aggressive expansion into new industrial data center properties. Community discourse remains deeply polarized, with some investors viewing the price drop as a strategic buying opportunity in a high-growth sector, while vocal critics are dismissing the move as corporate mismanagement and manipulation.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is surging after reporting robust Phase 3 trial results for avexitide in post-bariatric hypoglycemia, a milestone that significantly derisks its primary clinical asset. The rally has been further fueled by a $350 million equity offering and positive analyst coverage, leaving short sellers heavily exposed as the community debates the stock's future liquidity and growth potential.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing intense volatility as market participants fiercely debate the platform's long-term viability and its deep ties to Donald Trump's political brand. The discourse is dominated by polarized community sentiment, with discussions centering on the company's financial performance, potential for dilution, and the broader implications of the current administration's geopolitical policies.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is trending as investor focus intensifies on the strong commercial execution of its lead drug, Ibtrozi, and anticipation for future data readouts on its pipeline, including the glioma drug safusidenib. Community sentiment remains bullish, with many participants citing recent institutional accumulation and optimistic analyst coverage as catalysts for potential long-term upside.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors digest a strong earnings report and raised revenue guidance, fueling optimism for the company's growth trajectory and its blockbuster-potential asset, RECORLEV. The community is focused on the upcoming Phase 3 development of XP-8121, with many discussing the potential for a significant valuation re-rate as the company pivots toward profitability and expands its commercial presence.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing intense selling pressure as a landmark federal trial begins, with investors concerned over potential multibillion-dollar penalties and long-term business model changes. While the community is deeply divided between those viewing the legal risks as overblown buying opportunities and those concerned that the company's aggressive AI capital expenditure is unsustainable amid mounting regulatory headwinds.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending as investors digest a massive $7.8 billion acquisition of Arcellx, a strategic move to solidify its oncology leadership and gain full control of the promising multiple myeloma therapy anito-cel. The market is actively debating whether this bold M&A spree effectively positions the company for long-term growth or if the associated costs and pipeline integration risks will weigh on near-term performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Investors Undervaluing Cricut (CRCT) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Business Services Stocks Lagging  Cricut (CRCT) This Year?

Here is how Cricut, Inc. (CRCT) and Recruit Holdings Co., Ltd. (RCRUY) have performed compared to their sector so far this year.

Cricut, Inc. (CRCT) Tops Q2 Earnings Estimates

Cricut (CRCT) delivered earnings and revenue surprises of +375.00% and -6.89%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Principal Accounting Officer Of Cricut Makes $71K Sale

Bargain Bin Stocks: CRCT Now 10.6% Cheaper Than Director Makler's Buy

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 13, Cricut Inc's Director, Jason Makler, invested $43,390.49 into 10,001 shares of CRCT, for a cost per share of $4.34. Bargain hu...

Cricut (NASDAQ:CRCT) Announces Earnings Results

Cricut (NASDAQ:CRCT - Get Free Report) posted its earnings results on Tuesday. The company reported $0.10 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.05. The business had revenue of $159.47 million during the quarter, compared to analyst estimates of $164.33 million...

Cricut, Inc. (CRCT) Beats Q1 Earnings Estimates

Cricut (CRCT) delivered earnings and revenue surprises of +100.00% and -2.80%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cricut Q1 Earnings Call Highlights

Cricut (NASDAQ:CRCT) reported first-quarter 2026 revenue of $159.5 million, down 2% from the prior year, as higher platform revenue and improving user trends were offset by a decline in product...

Cricut Q1 2026 Earnings Call: Complete Transcript

Cricut (CRCT) to Release Earnings on Tuesday

Cricut (NASDAQ:CRCT) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-cricut-inc-stock...

$CRCT Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.19 up 58.33% YoY
• Reported revenue of $156.28M down -9.20% YoY

Cricut, Inc., distributes scrap book, craft and home decor items. The firm’s products include its flagship line of cutting machines, such as the Cricut Maker family, the Cricut Explore family, and Cricut Joy, accompanied by other tools like Cricut EasyPress, the Infusible Ink system, and a diverse collection of materials. It operates through the following segments: Connected Machines, Subscriptions, and Accessories & Materials. The company was founded by Robert Workman in June 1969 and is headquartered in South Jordan, UT.

Cricut Inc - Ordinary Shares - Class A

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.04	--	--	N/A
Q2 '26	$0.06	$0.19	236.28%	BEAT
Q1 '26	$0.04	$0.10	140.00%	BEAT
Q4 '25	$0.03	$0.04	50.00%	BEAT
Q3 '25	$0.04	$0.10	185.06%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings